Gliclazide Modified Release IP

Uses:
This medicine is commonly used for the management and treatment of conditions related to its therapeutic category. It helps in controlling symptoms, supporting effective treatment, and improving overall patient outcomes under medical supervision.

Variant (MG): 30, 60

Type: Blister

Packaging: 10X10TAB

Enquiry about this medicine

Other products you might be interested

Levocarnitine IP

Uses: This medicine is commonly used for the management and treatment of conditions related to its therapeutic category. It helps in controlling symptoms, supporting effective treatment, and improving overall patient

view this product »

Hydroxychloroquine Sulphate IP

Uses: This medicine is commonly used for the management and treatment of conditions related to its therapeutic category. It helps in controlling symptoms, supporting effective treatment, and improving overall patient

view this product »

Divalproex sodium IP

Uses: This medicine is commonly used for the management and treatment of conditions related to its therapeutic category. It helps in controlling symptoms, supporting effective treatment, and improving overall patient

view this product »

Olanzapine IP

Uses: This medicine is commonly used for the management and treatment of conditions related to its therapeutic category. It helps in controlling symptoms, supporting effective treatment, and improving overall patient

view this product »

Cefixime Dispersible IP

Uses: This medicine is commonly used for the management and treatment of conditions related to its therapeutic category. It helps in controlling symptoms, supporting effective treatment, and improving overall patient

view this product »

Ticagrelor IP

Uses: This medicine is commonly used for the management and treatment of conditions related to its therapeutic category. It helps in controlling symptoms, supporting effective treatment, and improving overall patient

view this product »